Lifesci Advisors, Llc

Lifesci Advisors, Llc company information, Employees & Contact Information

LifeSci Advisors is a unique investor relations consultancy founded to provide companies in the life sciences field with a comprehensive solution to investor communications and outreach. Our services are designed to increase our clients’ visibility within the investment community and to educate investors about the opportunity. We strive to effectively communicate each clients’ unique value proposition, building momentum for the investment. We begin with deep due diligence as we partner with each client to gain an unparalleled level of understanding of their business and the opportunities they are addressing. This in-depth knowledge allows us to be able to provide each client partner with thoughtful recommendations related to corporate communications, investor outreach, and capital markets planning. Our strategies and actions are specifically tailored to help each client achieve their investor relations goals.

Company Details

Employees
94
Founded
-
Address
250 W 55th St,
Phone
116465976979
Email
in****@****ors.com
Industry
Financial Services
NAICS
Finance and Insurance
Monetary Authorities-Central Bank
HQ
New York, New York
Looking for a particular Lifesci Advisors, Llc employee's phone or email?

Lifesci Advisors, Llc Questions

News

Apyx Medical (NASDAQ: APYX) to release quarterly results Nov. 6; call at 8:00 a.m. ET - Stock Titan

Apyx Medical (NASDAQ: APYX) to release quarterly results Nov. 6; call at 8:00 a.m. ET Stock Titan

Clene to Participate in a Panel Discussion at the Maxim Growth Summit - Investing News Network

Clene to Participate in a Panel Discussion at the Maxim Growth Summit Investing News Network

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences - Business Wire

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences Business Wire

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 - FinancialContent

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025 FinancialContent

Annexon Biosciences to Participate in Upcoming September Investor Conferences - Investing News Network

Annexon Biosciences to Participate in Upcoming September Investor Conferences Investing News Network

Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Finansavisen

Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Finansavisen

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Business Wire

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PR Newswire

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire

New partnership aims to advance vaccine against MERS coronavirus - CEPI

New partnership aims to advance vaccine against MERS coronavirus CEPI

Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin Accepted for Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting - Morningstar

Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin Accepted for Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting Morningstar

DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 - Business Wire

DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 Business Wire

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS - PR Newswire

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS PR Newswire

LifeSci Advisors Announces Appointment of Chris Howerton Ph.D. - GlobeNewswire

LifeSci Advisors Announces Appointment of Chris Howerton Ph.D. GlobeNewswire

Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - PR Newswire

Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire

LifeSci Advisors Appoints Lindsey Trickett to its Investor Relations Team - GlobeNewswire

LifeSci Advisors Appoints Lindsey Trickett to its Investor Relations Team GlobeNewswire

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes - Business Wire

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes Business Wire

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report - Yahoo Finance

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report Yahoo Finance

Picard Issues Statement on Intraday Stock Price - GlobeNewswire

Picard Issues Statement on Intraday Stock Price GlobeNewswire

Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC - Yahoo Finance

Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC Yahoo Finance

Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement - Yahoo Finance

Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement Yahoo Finance

Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference - Investing News Network

Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference Investing News Network

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization - Yahoo Finance

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization Yahoo Finance

Arrowhead Pharmaceuticals Closes Underwritten Offering with Gross Proceeds of $450.0 Million - Business Wire

Arrowhead Pharmaceuticals Closes Underwritten Offering with Gross Proceeds of $450.0 Million Business Wire

Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation - Yahoo Finance

Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation Yahoo Finance

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire

Nektar Sets Q2 2025 Earnings Release: CEO Howard Robin to Lead Financial Results Call August 7 - Stock Titan

Nektar Sets Q2 2025 Earnings Release: CEO Howard Robin to Lead Financial Results Call August 7 Stock Titan

NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition - Yahoo Finance

NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition Yahoo Finance

LifeSci Capital Appoints Healthcare Finance Veteran Brian Coleman as Head of Global Capital Markets - GlobeNewswire

LifeSci Capital Appoints Healthcare Finance Veteran Brian Coleman as Head of Global Capital Markets GlobeNewswire

Mainstay Medical Announces New ICD-10 Diagnosis Code for Multifidus Dysfunction - Business Wire

Mainstay Medical Announces New ICD-10 Diagnosis Code for Multifidus Dysfunction Business Wire

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024 - Stock Titan

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024 Stock Titan

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires - Business Wire

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires Business Wire

DocGo to Exhibit Innovative Vehicles at 2022 Subway Series Mets vs. Yankees Game in NYC - Business Wire

DocGo to Exhibit Innovative Vehicles at 2022 Subway Series Mets vs. Yankees Game in NYC Business Wire

Arrowhead Breaks Ground on New Manufacturing Facility with Wisconsin Governor Tony Evers and Announces Receipt of Incentives - Business Wire

Arrowhead Breaks Ground on New Manufacturing Facility with Wisconsin Governor Tony Evers and Announces Receipt of Incentives Business Wire

BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 - FinancialContent

BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 FinancialContent

Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant from Prima System French feasibility study - BioSpace

Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant from Prima System French feasibility study BioSpace

Beckley Psytech Strengthens Senior Leadership Team With Appointment of Dr. Laura Trespidi as Chief Development Officer - Business Wire

Beckley Psytech Strengthens Senior Leadership Team With Appointment of Dr. Laura Trespidi as Chief Development Officer Business Wire

DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event - FinancialContent

DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event FinancialContent

LifeSci Capital Announces Transition to Fully Independent, High-Conviction Research Coverage - GlobeNewswire

LifeSci Capital Announces Transition to Fully Independent, High-Conviction Research Coverage GlobeNewswire

GenSight Biologics Appoints Elsy Boglioli to Its Board of Directors - Business Wire

GenSight Biologics Appoints Elsy Boglioli to Its Board of Directors Business Wire

DiaMedica Therapeutics to Report Third Quarter 2021 Financial Results and Provide a Business Update November 11, 2021 - FinancialContent

DiaMedica Therapeutics to Report Third Quarter 2021 Financial Results and Provide a Business Update November 11, 2021 FinancialContent

Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - FinancialContent

Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) FinancialContent

Top Lifesci Advisors, Llc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant